(19)
(11) EP 1 017 828 A1

(12)

(43) Date of publication:
12.07.2000 Bulletin 2000/28

(21) Application number: 98948557.8

(22) Date of filing: 24.09.1998
(51) International Patent Classification (IPC)7C12N 15/57, C12N 9/52, A61K 38/48, C07K 16/40, C12N 1/21, C12N 5/10
(86) International application number:
PCT/US9820/186
(87) International publication number:
WO 9915/675 (01.04.1999 Gazette 1999/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 24.09.1997 US 59907 P

(71) Applicants:
  • REGENTS OF THE UNIVERSITY OF MINNESOTA
    MinneapolisMN 55455 (US)
  • AMERICAN CYANAMID COMPANY
    Madison, New Jersey 07940 (US)

(72) Inventors:
  • HOSTETTER, Margaret, K.
    New Haven, CT 06511 (US)
  • FINKEL, David, J.
    Minneapolis, MN 55414 (US)
  • CHENG, Qi
    Plymouth, MN 55442 (US)
  • GREEN, Bruce, A.
    Pittsford, NY 14534 (US)
  • MASI, Amy, W.
    Caledonia, NY 14423 (US)

(74) Representative: Perry, Robert Edward et al
GILL JENNINGS & EVERYBroadgate House7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)